OppenheimerFunds’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $15.5M | Sell |
50,819
-15,607
| -23% | -$4.77M | 0.02% | 597 |
|
2018
Q4 | $15.4M | Sell |
66,426
-12,843
| -16% | -$2.98M | 0.02% | 571 |
|
2018
Q3 | $24.8M | Buy |
79,269
+24,625
| +45% | +$7.71M | 0.03% | 529 |
|
2018
Q2 | $15.8M | Buy |
54,644
+10,833
| +25% | +$3.13M | 0.02% | 640 |
|
2018
Q1 | $11M | Buy |
43,811
+4,093
| +10% | +$1.02M | 0.01% | 681 |
|
2017
Q4 | $9.48M | Buy |
39,718
+837
| +2% | +$200K | 0.01% | 741 |
|
2017
Q3 | $8.64M | Sell |
38,881
-6,413
| -14% | -$1.43M | 0.01% | 761 |
|
2017
Q2 | $10.3M | Buy |
45,294
+13,304
| +42% | +$3.01M | 0.01% | 737 |
|
2017
Q1 | $6.38M | Buy |
31,990
+29,592
| +1,234% | +$5.9M | 0.01% | 818 |
|
2016
Q4 | $437K | Buy |
2,398
+418
| +21% | +$76.2K | ﹤0.01% | 1443 |
|
2016
Q3 | $324K | Sell |
1,980
-78
| -4% | -$12.8K | ﹤0.01% | 1462 |
|
2016
Q2 | $294K | Sell |
2,058
-32
| -2% | -$4.57K | ﹤0.01% | 1471 |
|
2016
Q1 | $286K | Sell |
2,090
-365
| -15% | -$49.9K | ﹤0.01% | 1470 |
|
2015
Q4 | $340K | Buy |
+2,455
| New | +$340K | ﹤0.01% | 1460 |
|